{"id":"c6956626-1d88-4292-b95e-9b29b8bad0a2","arxiv_id":"2506.07191","paper_version":1,"verdict":"REJECT","confidence":"MODERATE","novelty_score":2.0,"correctness_risk":"high","formal_verification":"none","parameter_count":2,"one_line_summary":"A SEER-based survival analysis claims racial disparities in breast cancer outcomes, but the reported numeric findings are unsupported and internally inconsistent.","lead":"This paper applies standard survival analysis tools (Kaplan-Meier curves and Cox regression) to SEER breast cancer records to compare survival by race and location. It claims findings such as a 17% lower survival rate for Native American patients and a negligible difference for Black patients, but it does not show the model output behind those numbers.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Central effect sizes in Section IV.D are unsupported by any reported hazard ratios, confidence intervals, or p-values, and conflict with the paper's own survival-curve summary.","rationale":"Reader's weakest_assumption, that the proportional hazards assumption holds, is a real issue, but the paper's failure to report the model output makes the central claim unassessable independently of PH. The strongest_claim depends entirely on two numbers that appear for the first time in a bulleted implications paragraph, with no supporting table, coefficient, interval, or test statistic. Section IV.C directly contradicts the direction of the Black effect. The reproduction check I propose would settle whether the 17% and 1% figures are reproducible from the stated data and model; if they are not, the central claim fails regardless of the PH assumption. I agree with the reader's REJECT verdict, so no verdict movement is needed.","tokens_in":9314,"tokens_out":3255,"duration_ms":33642,"concrete_test":"Obtain the SEER 21 Registries database (2021 submission), apply the preprocessing described in Section III.A, fit the Cox proportional hazards model described in Section III.B with race, age, sex, stage, median household income, and rural-urban continuum code, with cause-specific death as the event, and print the hazard ratio and 95% confidence interval for American Indian/Alaska Native and Black relative to White. Then compute Schoenfeld residual tests for proportional hazards. If the point estimates differ from the Section IV.D claims by more than sampling error, if the confidence intervals include 1, or if the PH tests reject, the paper's headline disparities are not established.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim is the pair of quantitative effect sizes in Section IV.D: Native Americans have a 17% lower survival rate than White patients, and Black patients show a 1% reduction in risk. These numbers are not backed by any reported hazard ratio, confidence interval, or p-value anywhere in the manuscript, and no table or figure displays the Cox model output that would justify them. Worse, Section IV.C's summary of the Kaplan-Meier analysis states that \"non-Hispanic White females consistently had better survival probabilities than other racial groups, with Hispanic and Black patients experiencing the lowest survival rates\"; a 1% reduction in risk for Black patients points in the opposite direction. This internal inconsistency means the reader cannot tell whether the 17% and 1% figures are hazard ratios, survival-probability differences, or something else, and cannot verify them against the SEER data. The paper's own caveat that the proportional hazards assumption may not hold across stratifications is never tested, but that issue is secondary: even if the model were valid, the reported effect sizes are unsupported as written.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper analyzes breast cancer survival disparities using the SEER 2021 dataset (96,789 records, 12 features) with exploratory data analysis, Kaplan-Meier curves, log-rank tests, and a Cox proportional hazards model. The stated contribution is a quantification of survival differences across racial and geographic groups, culminating in Section IV.D in the claims that Native American patients have a 17% lower survival rate than White patients and that Black patients have a 1% reduction in risk relative to White patients. The paper also discusses socioeconomic and rural-urban patterns and offers policy recommendations.","tokens_in":9635,"tokens_out":2342,"duration_ms":27068,"significance":"The topic is important: quantifying racial and geographic disparities in breast cancer survival is a substantive public-health question with direct policy relevance. However, the manuscript as written does not provide the statistical evidence needed to support its central quantitative claims. The paper gives no hazard ratios, confidence intervals, p-values, or model summaries for the Cox regression, and its own narrative in Section IV.C contradicts the headline numbers. If the results were rigorously established with full model output and diagnostic checks, the finding that Black patients have nearly identical risk to White patients would be notable, as would the Native American disadvantage; but in the current form the claims are unverifiable and internally inconsistent.","major_comments":[{"comment":"The central claims that 'Native Americans demonstrate a concerning 17% lower survival rate' and 'Black patients show a minor (1%) reduction in risk compared to White patients' are presented with no supporting hazard ratio, confidence interval, p-value, standard error, or model summary. No table or figure in the manuscript reports the Cox model coefficients or the number of events per group. Without these, the reader cannot determine whether the 17% and 1% figures are adjusted hazard ratios, survival-probability differences at a fixed time point, or some other quantity, and the numbers cannot be verified against the SEER data. This omission is load-bearing because these two numbers are the paper's main empirical findings.","section":"Section IV.D"},{"comment":"The paper is internally inconsistent about the Black-White comparison. Section IV.C states that Kaplan-Meier curves show 'Hispanic and Black patients experiencing the lowest survival rates,' while Section IV.D asserts that Black patients have only a 1% reduction in risk relative to White patients. If the Cox model adjusts for confounders that explain away most of the Black-White survival gap, that adjustment and its covariates must be reported; if the two statements refer to different quantities, the distinction is never explained. As written, the contradiction prevents the reader from knowing what the paper's actual finding is.","section":"Section IV.C and Section IV.D"},{"comment":"The Cox proportional hazards assumption is explicitly acknowledged as a possible problem: 'the assumption of proportional hazards in Cox models may not hold across all stratifications, potentially skewing the results in certain demographic segments.' However, no Schoenfeld residual test, time-varying coefficient analysis, log-log survival plot, or stratified baseline hazard approach is reported anywhere. Since the 17% and 1% claims are hazard-ratio-based, the potential violation of the PH assumption directly undermines their validity, yet the manuscript stops at the caveat without any diagnostic.","section":"Section III.B and Section IV.C"},{"comment":"The preprocessing section states that records with missing survival times, unclear staging, or undetermined race/ethnicity were removed, but it does not report the number or proportion of excluded records, nor does it address whether exclusions could introduce selection bias. Similarly, Section IV.B asserts that patients from rural areas 'generally displayed poorer survival outcomes' without presenting any quantitative comparison or supporting statistic. These are additional instances of the general pattern in which conclusions are stated without the numerical evidence that would let a reader assess their reliability.","section":"Section III.A and Section IV.B"}],"minor_comments":[{"comment":"The abstract says survival rates vary 'across racial groups and countries,' but the analysis uses SEER data from the United States and appears to examine counties or geographic regions within the US; 'countries' should be 'geographic locations' or 'regions.'","section":"Abstract"},{"comment":"The demographic analysis reports a 'nearly equal distribution of cancer incidence between genders, with females slightly outnumbering males.' For breast cancer, one would expect a very large female majority; the near-equal split is surprising and suggests either a reporting error or an unusual way of counting sex, and the paper should clarify this.","section":"Section IV.A"},{"comment":"Several related-works paragraphs describe studies but do not cite them in the text at the point of discussion; the references [2]–[10] are listed at the end but no in-text citation markers appear in the body, making it hard to match claims to sources.","section":"Section II"},{"comment":"The manuscript contains multiple typos and grammatical errors (e.g., 'algorithms' vs. 'analysis', 'data has been encoded', 'outcome of this paper is a detailed version'), which, while not affecting the scientific content, should be cleaned up in any revision.","section":"General"},{"comment":"The paper mentions 'Histograms and bar charts' and Kaplan-Meier curves, but no figures are included in the manuscript; either the figures should be provided or the text should state where they can be found.","section":"Section IV"}],"recommendation":"reject","confidential_remarks":"This manuscript does not meet the standards for publication in its current form because its central empirical claims are unverifiable: no model output, standard errors, or confidence intervals are reported, and the paper contradicts itself on the Black-White comparison. The appropriate path would be a full reanalysis with complete reporting, not a revision of the text. Given the scope of the missing evidence, I recommend rejection rather than major revision."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"What you need to know: this paper runs Kaplan-Meier, log-rank, and Cox on SEER breast cancer data and claims Native Americans have a 17% lower survival rate than White patients while Black patients show a 1% reduction in risk. Neither number is backed by any hazard ratio, confidence interval, p-value, or model table anywhere in the manuscript. Worse, Section IV.C says the opposite for Black patients: the KM curves show Black and Hispanic patients with the lowest survival rates. So the central claim is both unsupported and self-contradictory.\n\nTo its credit, the paper is clearly organized, uses a public dataset, and its limitations section honestly notes incomplete SES data, broad race categories, and the retrospective design. It also acknowledges that the proportional hazards assumption may not hold across stratifications. That tells me the authors know the standard caveats; they just didn't act on them.\n\nThe biggest problem is that the results section never reports any actual model output. The methodology says hazard ratios were computed, but Section IV.D just states two percentages with no uncertainty, no covariate adjustment details, and no sample sizes per group. That makes the numbers impossible to verify and impossible to take seriously. The inconsistency with IV.C is not a minor quibble—it flips the Black patient finding from worst-off to nearly identical to White patients. Also missing: any test of the PH assumption (Schoenfeld residuals or time-varying coefficients), any code or data-processing details, and any external comparison to the prior estimates cited in the paper. The related works section also has some odd claims—ref [4] is described as finding Black and Hispanic women less likely to be diagnosed early, which contradicts the actual literature's direction.\n\nThis reads like a course project or a preliminary exploratory analysis. The broad finding that racial disparities exist is well documented, so the paper adds nothing new empirically. The only potentially new numbers are the unsupported ones.\n\nIf this landed on my desk as an editor, I wouldn't send it to peer review in its current state. The central evidential basis is missing, and the internal contradiction would have to be resolved first. I'd desk-reject, or at most send it back for a full results table and a serious re-analysis. Not a reading group candidate either.","headline":"The headline numbers in Section IV.D rest on no reported statistics and contradict the paper's own survival-curve summary; as written this is not a publishable result.","tokens_in":10040,"tokens_out":2781,"would_cite":false,"duration_ms":30589,"reading_group":"no","serious_thinker":"no","would_accept_peer_review":false},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"On SEER 2021 data, Native American breast cancer patients show a 17% lower survival rate than White patients, while Black patients show near parity.","keywords":["breast cancer survival","racial disparities","SEER dataset","Kaplan-Meier estimator","Cox proportional hazards model","log-rank test","Native American survival","rural-urban disparities"],"falsifier":"Re-estimate the Cox model on the same SEER records and compute Schoenfeld residuals, or fit a model with time-varying race coefficients. If the residuals show a significant trend over survival time, or if a 95% confidence interval for the Native American hazard ratio includes 1.0, the paper's 17% claim is not supported.","tokens_in":9101,"feed_emoji":"🎗️","tokens_out":8685,"duration_ms":82982,"temperature":0.7,"pith_summary":"This paper sets out to quantify how breast cancer survival differs by race and geographic location using the SEER 2021 registry, a population-based cancer database covering 96,789 patient records. Applying Kaplan-Meier survival curves, log-rank tests, and a Cox proportional hazards model, the authors claim that Native American patients have a 17% lower survival rate than White patients, while Black patients show a 1% reduction in risk relative to White patients. They also report that patients in rural areas generally fare worse than urban patients and that later stage at diagnosis is strongly tied to poorer survival. If these estimates are right, the largest survival deficit in the SEER population sits with Native Americans, and the widely reported Black-White survival gap is much smaller than commonly assumed in this dataset. The paper intends these results to guide targeted public-health interventions.","feed_headline":"17% lower breast cancer survival for Native Americans in SEER data","feed_subtitle":"Survival modeling of 96,789 SEER records puts Native Americans at the biggest deficit; Black patients near White parity.","key_machinery":"The engine of the paper is the Cox proportional hazards model applied to survival times from the SEER 2021 dataset, with hazard ratios comparing each racial group against the White reference category. A hazard ratio is the ratio of mortality risk between two groups at a given time, so the reported figures translate directly into percentage differences in risk. The Kaplan-Meier estimator and log-rank test supply the unadjusted group comparisons that precede the Cox model, while rural-urban continuum codes and stage at diagnosis enter as covariates. The paper's inferential weight rests on the assumption that these hazard ratios are constant over follow-up time, an assumption the authors concede may not hold across all stratifications.","core_discovery":"On the paper's own terms, the central discovery is that race and rural-urban location are measurable survival predictors in a large national cancer registry, and the ordering of racial disparities is not the one emphasized in much prior literature. In the Cox model, Native Americans carry the largest disadvantage, with a reported 17% lower survival rate relative to White patients, whereas Black patients show a 1% reduction in risk compared with White patients, i.e., near parity. Kaplan-Meier curves and log-rank tests are used to support the unadjusted comparisons, and the paper interprets earlier diagnosis as the main protective factor because localized-stage patients survive markedly longer than regional or distant-stage patients. The authors take these findings as evidence that screening and treatment access, especially in underserved communities, should be the focus of disparity-reduction policy.","pith_inferences":["This reader's inference: the Native American estimate comes from a subgroup that is only 0.3% of the cohort, so without reported confidence intervals the 17% figure may be statistically fragile.","This reader's inference: a Schoenfeld residual test or time-varying coefficient model would test whether the proportional-hazards assumption, which the paper itself flags, actually holds; if it fails, the headline hazard ratios would need to be replaced by time-dependent estimates.","This reader's inference: the near-parity Black estimate may pool together very different tumor subtypes and treatment histories; sub-group analyses by hormone-receptor status could reveal larger Black-White gaps hidden in the aggregate."],"forward_implications":["Native American patients in SEER-covered regions would become the highest-priority group for screening outreach and treatment-access programs.","A 1% Black-White difference would imply that, in this dataset, the long-standing Black survival disadvantage is not visible and that disparity research should be redirected toward Native American and rural populations.","Rural residence as a survival disadvantage would point to healthcare infrastructure and access, rather than race alone, as drivers of at least part of the survival gap.","The strong stage-survival gradient would imply that early detection remains the most direct lever for reducing mortality disparities.","Policymakers would need to combine race-specific and geography-specific interventions rather than treating minority status as a single risk category."],"supporting_citations":[{"why":"It supplies the SEER 2021 dataset with 96,789 breast cancer records from which all survival estimates are computed.","marker":"[1]"},{"why":"It documents the healthcare-system, patient, and provider factors used to frame why racial survival disparities exist.","marker":"[2]"},{"why":"It provides the systematic-review baseline of Black-White survival gaps that the paper's 1% Black estimate revises.","marker":"[6]"},{"why":"It supplies a non-U.S. comparison showing Black women at higher mortality risk, which contextualizes the near-parity finding.","marker":"[8]"},{"why":"It presents the established U.S. Black-White mortality gap that the paper's Native American and Black findings depart from.","marker":"[9]"},{"why":"It summarizes U.S. racial and ethnic disparity literature against which the paper positions its SEER-based results.","marker":"[10]"}],"fun_headline_variants":["Native American breast cancer survival 17% lower in SEER","Breast cancer gap: Native Americans down 17%, Blacks near parity","SEER survival study: Native Americans 17% worse than Whites","Native Americans lead with 17% lower breast cancer survival in SEER","Breast cancer survival: Native American deficit 17%, Black parity"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The load-bearing premise is that the relative survival gap between each racial group and White patients stays constant over time; if it changes, the reported 17% and 1% figures are not trustworthy, and the paper itself notes that this assumption may fail.","fun_headline_variants_meta":{"raw":{"variants":["Native American breast cancer survival 17% lower in SEER","Breast cancer gap: Native Americans down 17%, Blacks near parity","SEER survival study: Native Americans 17% worse than Whites","Native Americans lead with 17% lower breast cancer survival in SEER","Breast cancer survival: Native American deficit 17%, Black parity"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.001015,"raw_usage":{"total_tokens":4251,"prompt_tokens":874,"completion_tokens":3377,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":490,"completion_tokens_details":{"reasoning_tokens":3285}},"tokens_in":490,"tokens_out":3377,"duration_ms":26109,"temperature":1.0,"reasoning_tokens":3285,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-07T05:39:28.022749+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Re-estimate the Cox model on the same SEER records and compute Schoenfeld residuals, or fit a model with time-varying race coefficients. If the residuals show a significant trend over survival time, or if a 95% confidence interval for the Native American hazard ratio includes 1.0, the paper's 17% claim is not supported.","supporting_citations":[{"cited_title":"Racial Disparities in Breast Cancer Survival in Brazil's Public Healthcare System,","cited_arxiv_id":null,"evidence_quote":"It supplies a non-U.S. comparison showing Black women at higher mortality risk, which contextualizes the near-parity finding."}],"review_version":1}